255 related articles for article (PubMed ID: 31127314)
41. Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes.
Mutter S; Valo E; Aittomäki V; Nybo K; Raivonen L; Thorn LM; Forsblom C; Sandholm N; Würtz P; Groop PH
Diabetologia; 2022 Jan; 65(1):140-149. PubMed ID: 34686904
[TBL] [Abstract][Full Text] [Related]
42. Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.
Forsblom C; Moran J; Harjutsalo V; Loughman T; Wadén J; Tolonen N; Thorn L; Saraheimo M; Gordin D; Groop PH; Thomas MC;
Diabetes Care; 2014 Aug; 37(8):2334-42. PubMed ID: 24879837
[TBL] [Abstract][Full Text] [Related]
43. Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes.
Panduru NM; Forsblom C; Saraheimo M; Thorn L; Bierhaus A; Humpert PM; Groop PH;
Diabetes Care; 2013 Jul; 36(7):2077-83. PubMed ID: 23378622
[TBL] [Abstract][Full Text] [Related]
44. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
Penno G; Russo E; Garofolo M; Daniele G; Lucchesi D; Giusti L; Sancho Bornez V; Bianchi C; Dardano A; Miccoli R; Del Prato S
Diabetologia; 2017 Jun; 60(6):1102-1113. PubMed ID: 28357502
[TBL] [Abstract][Full Text] [Related]
45. High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality.
Grauen Larsen H; Marinkovic G; Nilsson PM; Nilsson J; Engström G; Melander O; Orho-Melander M; Schiopu A
Arterioscler Thromb Vasc Biol; 2019 May; 39(5):925-933. PubMed ID: 30917679
[TBL] [Abstract][Full Text] [Related]
46. Effects of dried okra extract on lipid profile, renal function and some RAGE-related inflammatory genes expression in patients with diabetic nephropathy: A randomized controlled trial.
Bahreini N; Saghafi-Asl M; Nikpayam O; Safaei E; Sadra V; Fakhr L; Beyrampour-Basmenj H; Asgharian P; Asghari-Jafarabadi M
Complement Ther Med; 2024 May; 81():103027. PubMed ID: 38336011
[TBL] [Abstract][Full Text] [Related]
47. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
Prasad K
Mol Cell Biochem; 2019 Jan; 451(1-2):139-144. PubMed ID: 29961210
[TBL] [Abstract][Full Text] [Related]
48. Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products.
Liebisch M; Bondeva T; Franke S; Hause S; Wolf G
Nephrol Dial Transplant; 2017 Apr; 32(4):641-653. PubMed ID: 27638909
[TBL] [Abstract][Full Text] [Related]
49. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
Tan SMQ; Chiew Y; Ahmad B; Kadir KA
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
[TBL] [Abstract][Full Text] [Related]
50. A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes.
Salonen KM; Ryhänen SJ; Forbes JM; Härkönen T; Ilonen J; Simell O; Veijola R; Groop PH; Knip M
Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 27883367
[TBL] [Abstract][Full Text] [Related]
51. RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
Matsui T; Higashimoto Y; Nishino Y; Nakamura N; Fukami K; Yamagishi SI
Diabetes; 2017 Jun; 66(6):1683-1695. PubMed ID: 28385802
[TBL] [Abstract][Full Text] [Related]
52. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy.
Forbes JM; Thorpe SR; Thallas-Bonke V; Pete J; Thomas MC; Deemer ER; Bassal S; El-Osta A; Long DM; Panagiotopoulos S; Jerums G; Osicka TM; Cooper ME
J Am Soc Nephrol; 2005 Aug; 16(8):2363-72. PubMed ID: 15930093
[TBL] [Abstract][Full Text] [Related]
53. Cross-sectional Analysis of AGE-CML, sRAGE, and esRAGE with Diabetes and Cardiometabolic Risk Factors in a Community-Based Cohort.
Loomis SJ; Chen Y; Sacks DB; Christenson ES; Christenson RH; Rebholz CM; Selvin E
Clin Chem; 2017 May; 63(5):980-989. PubMed ID: 28280052
[TBL] [Abstract][Full Text] [Related]
54. Telomere length and progression of diabetic nephropathy in patients with type 1 diabetes.
Fyhrquist F; Tiitu A; Saijonmaa O; Forsblom C; Groop PH;
J Intern Med; 2010 Mar; 267(3):278-86. PubMed ID: 19563389
[TBL] [Abstract][Full Text] [Related]
55. Activation of tubular epithelial cells in diabetic nephropathy.
Morcos M; Sayed AA; Bierhaus A; Yard B; Waldherr R; Merz W; Kloeting I; Schleicher E; Mentz S; Abd el Baki RF; Tritschler H; Kasper M; Schwenger V; Hamann A; Dugi KA; Schmidt AM; Stern D; Ziegler R; Haering HU; Andrassy M; van der Woude F; Nawroth PP
Diabetes; 2002 Dec; 51(12):3532-44. PubMed ID: 12453911
[TBL] [Abstract][Full Text] [Related]
56. Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.
Pena MJ; Lambers Heerspink HJ; Hellemons ME; Friedrich T; Dallmann G; Lajer M; Bakker SJ; Gansevoort RT; Rossing P; de Zeeuw D; Roscioni SS
Diabet Med; 2014 Sep; 31(9):1138-47. PubMed ID: 24661264
[TBL] [Abstract][Full Text] [Related]
57. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
[TBL] [Abstract][Full Text] [Related]
58. FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic rats.
Sanajou D; Ghorbani Haghjo A; Argani H; Roshangar L; Ahmad SNS; Jigheh ZA; Aslani S; Panah F; Rashedi J; Mesgari Abbasi M
J Physiol Biochem; 2018 Aug; 74(3):467-478. PubMed ID: 29948786
[TBL] [Abstract][Full Text] [Related]
59. Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients.
Prevost G; Fajardy I; Besmond C; Balkau B; Tichet J; Fontaine P; Danze PM; Marre M;
Diabetes Metab; 2005 Feb; 31(1):35-9. PubMed ID: 15803111
[TBL] [Abstract][Full Text] [Related]
60. Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy.
Adler SG; Kang SW; Feld S; Cha DR; Barba L; Striker L; Striker G; Riser BL; LaPage J; Nast CC
Kidney Int; 2001 Dec; 60(6):2330-6. PubMed ID: 11737607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
